Related Experiment Video
Updated: May 5, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and
Tidi Hassan1, Tomás P Carroll, Patrick G Buckley
11 Respiratory Research Division, Department of Medicine, and.
Rationale:
Retention of abnormal α1-antitrypsin (AAT) activates the unfolded protein response in AAT-deficient monocytes. The regulatory role of microRNAs (miRNAs) in unfolded protein responses and chronic obstructive pulmonary disease pathogenesis has not been investigated.
Objectives:
To investigate miRNA expression and function in MM and ZZ monocytes and identify miRNA(s) regulating the unfolded protein response.
Methods:
Peripheral blood monocytes were isolated from asymptomatic and symptomatic MM and ZZ individuals for miRNA expression profiling and pyrosequencing analysis. miRNA/gene and protein expression was measured with quantitative polymerase chain reaction and Western blotting. Overexpression and inhibition studies were performed with pre-miR or anti-miR, respectively. Luciferase reporter genes were used to elucidate direct miRNA-target interactions. Inflammatory cytokines were detected using the Meso Scale Discovery Plex assays.
Measurements And Main Results:
Forty-three miRNAs were differentially expressed, with miR-199a-5p most highly up-regulated in asymptomatic ZZ versus MM monocytes. miR-199a-2 promoter hypermethylation inhibits miR-199a-5p expression and was increased in symptomatic MM and ZZ monocytes compared with asymptomatic counterparts. GRP78, activating transcription factor 6, p50, and p65 were increased in symptomatic versus asymptomatic ZZ monocytes. Reciprocal down- or up-regulation of these markers was observed after miRNA modulation. Direct miR-199a-5p targeting of activating transcription factor 6, p50, and p65 by miR-199a-5p was demonstrated using luciferase reporter systems. Overexpression of miR-199a-5p also decreased other arms of the UPR and expression of cytokines that are not putative targets.
Conclusions:
miR-199a-5p is a key regulator of the unfolded protein response in AAT-deficient monocytes, and epigenetic silencing of its expression regulates this process in chronic obstructive pulmonary disease.
Insights
MicroRNAs regulate the unfolded protein response in alpha-1 antitrypsin deficiency. Epigenetic silencing of miR-199a-5p in monocytes is linked to chronic obstructive pulmonary disease progression.
Area of Science:
- Cellular and Molecular Biology
- Pulmonary Medicine
- Epigenetics
Background:
- Alpha-1 antitrypsin (AAT) deficiency causes abnormal protein buildup, activating the unfolded protein response (UPR) in monocytes.
- The role of microRNAs (miRNAs) in UPR and chronic obstructive pulmonary disease (COPD) pathogenesis remains unclear.
Purpose of the Study:
- Investigate miRNA expression and function in MM and ZZ AAT-deficient monocytes.
- Identify specific miRNAs that regulate the UPR in the context of AAT deficiency and COPD.
Main Methods:
- Monocyte isolation from MM and ZZ individuals (asymptomatic vs. symptomatic).
- miRNA expression profiling, pyrosequencing, quantitative PCR, and Western blotting.
- Luciferase reporter assays to confirm miRNA-target interactions and functional studies using pre-miR/anti-miR.
Main Results:
- Forty-three differentially expressed miRNAs identified; miR-199a-5p was significantly upregulated in asymptomatic ZZ monocytes.
- Promoter hypermethylation of miR-199a-2 correlated with increased UPR markers (GRP78, ATF6, p50, p65) in symptomatic monocytes.
- miR-199a-5p directly targets ATF6, p50, and p65, modulating UPR and cytokine expression.
Conclusions:
- miR-199a-5p is a critical regulator of the UPR in AAT-deficient monocytes.
- Epigenetic silencing of miR-199a-5p contributes to COPD pathogenesis by dysregulating the UPR.
Related Concept Videos
The Unfolded Protein Response
Regulation of the Unfolded Protein Response
MicroRNAs
MicroRNAs
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

